- Unilever reported a second-quarter revenue of €15.36 billion, which was below the estimated €15.61 billion.
- The dividend per share for this period was set at €0.4528.
- In the Beauty & Wellbeing sector, the underlying operating profit was €1.26 billion, slightly below the expected €1.3 billion.
- The Personal Care segment reported an underlying operating profit of €1.44 billion, missing the target of €1.48 billion.
- Home Care exceeded expectations with a reported underlying operating profit of €915 million compared to the estimated €893.1 million.
- Ice Cream’s underlying operating profit was €658 million, falling short of the forecasted €683.3 million.
- Unilever predicts an improvement in underlying operating margins for the full year, with a target of at least 18.5% in the second half, marking a significant increase from the second half of 2024.
- The company’s stock is rated with 18 buy recommendations, 6 holds, and 3 sells by analysts.
A look at Unilever PLC Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 3 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 2.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Unilever PLC, a renowned manufacturer of consumer goods, shows a promising long-term outlook based on its Smartkarma Smart Scores. With solid scores in key areas such as Dividend, Growth, Resilience, and Momentum, the company positions itself as a reliable investment option. A moderate Value score suggests that the company is reasonably priced, making it potentially attractive for investors seeking stability and growth. Unilever PLC, known for its diverse range of products spanning food, detergents, fragrances, and personal care items, exhibits resilience and momentum in its operations.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
